Prothena Corp Public (PRTA) Times Interest Earned (2012 - 2026)
Prothena Corp Public (PRTA) posted quarterly Times Interest Earned of $37.54 for Q1 2026, up 140.07% year-over-year from $15.64 in Q1 2025, and up 224.1% quarter-over-quarter from -$30.25 in Q4 2025.
Prothena Corp Public (PRTA) Times Interest Earned (2012 - 2026) Analysis & Trends
Prothena Corp Public's Times Interest Earned history runs 15 years deep, the most recent figure standing at $37.54 for Q1 2026.
- In Q1 2026, Times Interest Earned rose 140.07% year-over-year to $37.54; the TTM figure through Mar 2026 stood at -$38.39 (up 22.44% YoY), while the FY2025 annual figure was -$0.81, down 3.6% from the prior year.
- Times Interest Earned for Q1 2026 stood at $37.54, up from -$30.25 in the prior quarter.
- The five-year high for Times Interest Earned was $83.4 in Q2 2024, with the low at -$163.06 in Q1 2024.
- The 5-year median for Times Interest Earned is -$30.25 (2025), against an average of -$32.18.
- The sharpest annual moves came in 2023 and 2024: Times Interest Earned surged 38872.84% in 2023, then plunged 1574.87% in 2024.
- Prothena Corp Public's Times Interest Earned stood at -$0.04 in 2022, then soared by 38872.84% to $17.45 in 2023, then slumped by 631.36% to -$92.71 in 2024, then jumped by 67.37% to -$30.25 in 2025, then soared by 224.1% to $37.54 in 2026.
- Business Quant data shows PRTA's Times Interest Earned at $37.54 in Q1 2026, -$30.25 in Q4 2025, and -$50.3 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Prothena Corp Public | 458.45 Mn | 170.25 Mn | - | -2.82 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.82 |
| Mar 31, 2026 | 37.54 |
| Dec 31, 2025 | -30.25 |
| Sep 30, 2025 | -50.30 |
| Jun 30, 2025 | -7.86 |
| Mar 31, 2025 | -93.69 |
| Dec 31, 2024 | -92.71 |
| Sep 30, 2024 | -95.02 |
| Jun 30, 2024 | 83.40 |
| Mar 31, 2024 | -163.06 |
| Dec 31, 2023 | 17.45 |
| Sep 30, 2023 | 6.44 |
| Jun 30, 2023 | -41.57 |
| Mar 31, 2023 | -35.20 |
| Dec 31, 2022 | -0.05 |
| Sep 30, 2022 | -31.46 |
| Jun 30, 2022 | -27.01 |
| Mar 31, 2022 | -23.72 |
| Dec 31, 2021 | -20.68 |
| Sep 30, 2021 | 72.82 |